Literature DB >> 24419429

Stereotactic body radiotherapy for stage I NSCLC: the challenge of evidence-based medicine.

Matthias Guckenberger1.   

Abstract

Mesh：

Year:  2014        PMID： 24419429     DOI： 10.1097/JTO.0000000000000080

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

Review 1.  Is surgery still the optimal treatment for stage I non-small cell lung cancer?

Authors:  Drew Moghanaki; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2016-04

2.  Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients.

Authors:  Ming Li; Xiao Xu; Yingyi Qin; Peng Zhang; Changxing Shen; Qing Xia; Lihong Fan
Journal:  J Cancer       Date:  2021-03-19       Impact factor: 4.207

3.  Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study.

Authors:  Akifumi Miyakawa; Yuta Shibamoto; Fumiya Baba; Yoshihiko Manabe; Taro Murai; Chikao Sugie; Takeshi Yanagi; Taiki Takaoka
Journal:  Radiat Oncol       Date:  2017-09-11       Impact factor: 3.481
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.